BeOne Medicines at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

BeOne Medicines brings 3 presentations to SCOPE 2027 in Orlando. Its sessions center on risk-based quality management and making it work at scale. A distinctive argument is that risk assessment must reach beyond individual studies.

OrganizationSCOPE 2027 Attendance
beonemedicines.com
Biotech
Global oncology company, formerly BeiGene, developing and marketing cancer medicines.
Talk
Tue Mar 2
12:20pm–12:45pm
Seeing the Bigger Picture: Why Risk Assessment Must Extend beyond Individual Studies
Quality & Monitoring
Panel
Wed Mar 3
3:25pm–3:50pm
From Data Noise to Decision: Making RBQM Work at Scale
Plenary · with Pfizer, Roche
Quality, monitoring and safety
Panel
Thu Mar 4
9:25am–9:50am
RBQM Success Depends on CRAs: Are Sponsors and CROs Doing Enough?
Quality & Monitoring · with Gilead Sciences

Explore the full SCOPE 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full SCOPE 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from BeOne Medicines

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction